[Community-acquired pneumonia requiring hospitalization in immunocompetent elderly patients: clinical features, prognostic factors and treatment]
- PMID: 12890400
- DOI: 10.1016/s0300-2896(03)75400-3
[Community-acquired pneumonia requiring hospitalization in immunocompetent elderly patients: clinical features, prognostic factors and treatment]
Abstract
Background: Community-acquired pneumonia (CAP) is the leading cause of death from infectious disease among the elderly. This study was carried out to examine the clinical manifestations, etiology, prognostic factors and treatment of CAP in immunocompetent elderly patients requiring hospitalization.
Results: A total of 306 elderly (80 +/- 7 years) patients were evaluated: 54% were male, 89% had concurrent diseases (principally cardiovascular and neurological disease, chronic obstructive lung disease and diabetes), and 97% were treated with second-or third-generation cephalosporins. Mean hospital stay was 10 days, and mortality was approximately 10% in hospital and around 13% on follow up at 30 days. As compared to younger CAP patients, multiple comorbidity, altered mental status, hypoxemia, high serum urea nitrogen on hospital admission were more frequent in the elderly. Intermediate care and intensive care unit admissions were also more frequent in the elderly. Hospital length of stay as well as mortality in the hospital and at 30 days were higher in elderly patients. The pathogen was identified as part of routine care in around 25% of cases. The most frequent pathogens were Streptococcus pneumoniae (10.5%), enteric Gram negative bacilli (5.2%), Staphylococcus aureus (4.2%) and Haemophilus influenzae (3.9%). In multivariate analysis the prognostic factors on admission associated with in-hospital mortality were advanced age (> 83 years), absence of cough, low blood pressure and hyperphosphatemia.
Conclusion: CAP in elderly patients is a prevalent disease with specific clinical and epidemiological characteristics, clinical course and prognosis.
Similar articles
-
[Community-acquired pneumonia in hospitalized adult patients. Clinical presentation and prognostic factors].Rev Med Chil. 2002 Dec;130(12):1373-82. Rev Med Chil. 2002. PMID: 12611238 Spanish.
-
[Prognostic factors and outcome of community-acquired pneumonia in hospitalized adult patients].Rev Med Chil. 2006 Nov;134(11):1357-66. doi: 10.4067/s0034-98872006001100002. Epub 2007 Jan 2. Rev Med Chil. 2006. PMID: 17277848 Spanish.
-
[Etiology and prognostics factors of community-acquired pneumonia among adults patients admitted to a regional hospital in Chile].Rev Med Chil. 2006 May;134(5):597-605. doi: 10.4067/s0034-98872006000500008. Epub 2006 Jun 19. Rev Med Chil. 2006. PMID: 16802052 Spanish.
-
The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review.Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1065-79. doi: 10.1007/s10096-014-2067-1. Epub 2014 Feb 15. Eur J Clin Microbiol Infect Dis. 2014. PMID: 24532008 Free PMC article. Review.
-
Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.Scand J Infect Dis Suppl. 1995;97:1-60. Scand J Infect Dis Suppl. 1995. PMID: 8584866 Review.
Cited by
-
Serum inorganic phosphorus levels predict 30-day mortality in patients with community acquired pneumonia.BMC Infect Dis. 2015 Aug 13;15:332. doi: 10.1186/s12879-015-1094-6. BMC Infect Dis. 2015. PMID: 26268323 Free PMC article.
-
Community-acquired pneumonia in critically ill very old patients: a growing problem.Eur Respir Rev. 2020 Feb 19;29(155):190126. doi: 10.1183/16000617.0126-2019. Print 2020 Mar 31. Eur Respir Rev. 2020. PMID: 32075858 Free PMC article. Review.
-
Factors associated with hospital admission in patients reaching the emergency department with COPD exacerbation.Multidiscip Respir Med. 2012 Jun 19;7(1):6. doi: 10.1186/2049-6958-7-6. Multidiscip Respir Med. 2012. PMID: 22958396 Free PMC article.
-
Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes.Open Med (Wars). 2023 Oct 27;18(1):20230822. doi: 10.1515/med-2023-0822. eCollection 2023. Open Med (Wars). 2023. PMID: 37900963 Free PMC article.
-
Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors.Eur J Clin Microbiol Infect Dis. 2005 Jun;24(6):367-76. doi: 10.1007/s10096-005-1347-1. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15944847 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous